Alkermes ALKS
NASDAQ ALKS
$45.31 -0.18 (-0.40%)
As of: Sep 9, 2026 · 2:08 PM EDT

Alkermes (ALKS) EV to EBITDA (2010 - 2026)

Alkermes' (ALKS) quarterly EV to EBITDA came in at 442.58 in Q2 2026, up 1010.21% year-over-year from 39.86 in Q2 2025, and up 497.59% quarter-over-quarter from 111.31 in Q1 2026.

Analysis

Alkermes (ALKS) EV to EBITDA (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported EV to EBITDA for 17 consecutive years, with 442.58 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, EV to EBITDA rose 1010.21% year-over-year to 442.58 in Q2 2026; TTM through Jun 2026 was 69.27, a 599.37% increase from a year earlier, with the FY2025 full-year figure at 13.84, up 48.76% from the prior year.
  • EV to EBITDA was 442.58 for Q2 2026 at Alkermes, up from 111.31 in the prior quarter.
  • Over five years, EV to EBITDA peaked at 442.58 in Q2 2026 and troughed at 371.92 in Q1 2023.
  • A 5-year average of 25.1 and a median of 33.22 in 2024 frame the typical range for EV to EBITDA.
  • Across the five-year window, EV to EBITDA plunged 162.6% in 2023 and surged 1010.21% in 2026, its largest moves.
  • Over 5 years, EV to EBITDA stood at 31.89 in 2022, then surged by 121.45% to 70.63 in 2023, then plunged by 65.95% to 24.05 in 2024, then surged by 151.47% to 60.48 in 2025, then jumped by 631.82% to 442.58 in 2026.
  • The last three EV to EBITDA figures came in at 442.58 (Q2 2026), 111.31 (Q1 2026), and 60.48 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.92 Bn 626.16 Bn 17.26 Bn
2 AbbVie 441.93 Bn 435.36 Bn 12.70 Bn
3 Merck 365.88 Bn 358.74 Bn 12.21 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn
5 Pfizer 159.09 Bn 147.39 Bn 10.94 Bn
6 Sanofi 52.44 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.05 Bn 44.05 Bn -
8 Incyte 25.31 Bn 20.78 Bn 1.57 Bn
9 United Therapeutics 21.45 Bn 18.78 Bn 683.80 Mn
10 Alkermes 7.57 Bn 6.91 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 442.58
Mar 31, 2026 -111.31
Dec 31, 2025 60.48
Sep 30, 2025 43.13
Jun 30, 2025 39.86
Mar 31, 2025 330.59
Dec 31, 2024 24.05
Sep 30, 2024 34.55
Jun 30, 2024 28.41
Mar 31, 2024 88.54
Dec 31, 2023 70.63
Sep 30, 2023 42.39
Jun 30, 2023 15.58
Mar 31, 2023 -371.92
Dec 31, 2022 31.89
Sep 30, 2022 -50.93
Jun 30, 2022 -125.13
Mar 31, 2022 -141.63
Dec 31, 2021 24.96
Sep 30, 2021 -225.14